Cargando…
Hochhaus et al. Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment. Blood. 2008;111:1039-1043.
| Formato: | Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464565/ http://dx.doi.org/10.1182/blood-2008-05-158873 |